Submit Manuscript  

Article Details


Systemic Therapies for Metastatic Testicular Germ Cell Tumors– Past, Present, and Future

Author(s):

Sunil Parimi*, Jennifer Rauw and Jenny Ko   Pages 1 - 14 ( 14 )

Abstract:


Testicular germ cell tumors (TGCTs) are unique to that of most other solid tumors because they are highly curable in the metastatic setting. While the use of cisplatin-based chemotherapy continues to drive cure in this patient population, important improvements in the delivery of therapy, creation of risk-adjusted treatment paradigms, and salvage-therapy options have further enhanced survival as well. The future holds promise for a more multidisciplinary approach to care, through advancements in biochemical markers and a better understanding of how surgical and radiotherapy approaches can integrate into our existing management strategies.

Keywords:

metastatic, systemic therapies, risk stratification, testicular germ cell tumor

Affiliation:

BC Cancer Agency, Medical Oncology, BC Cancer Agency, Medical Oncology, BC Cancer Agency, Medical Oncology



Read Full-Text article